Chao Qi

Chao Qi


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2024 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
JZJing Zhang
Jing Zhang
DHDie Hu
Die Hu
LLLiping Li
Liping Li
DQDi Qu
Di Qu
WSWeipeng Shi
Weipeng Shi
HFHaitao Fu
Haitao Fu

17 February 2022 in Frontiers in Neuroscience
Verified
Journal Article
Open access
HFHaitao Fu
Haitao Fu
DHDie Hu
Die Hu
JCJinli Chen
Jinli Chen
QWQizun Wang
Qizun Wang
YZYingze Zhang
Yingze Zhang
TYTengbo Yu
Tengbo Yu
Spinal cord injury (SCI) can result in sensorimotor impairments or disability. Studies of the cellular response to SCI have increased our understanding of nerve regenerative failure following spinal cord trauma. Biological, engineering and rehabilitation strategies for repairing the injured spinal cord have shown impressive results in SCI models of both rodents and non-human primates. Cell transplantation, in particular, is becoming a highly promising approach due to the cells’ capacity to provide multiple benefits at the molecular, cellular, and circuit levels. While various cell types have been investigated, we focus on the use of Schwann cells (SCs) to promote SCI repair in this review. Transplantation of SCs promotes functional recovery in animal models and is safe for use in humans with subacute SCI. The rationales for the therapeutic use of SCs for SCI include enhancement of axon regeneration, remyelination of newborn or sparing axons, regulation of the inflammatory response, and maintenance of the survival of damaged tissue. However, little is known about the molecular mechanisms by which transplanted SCs exert a reparative effect on SCI. Moreover, SC-based therapeutic strategies face considerable challenges in preclinical studies. These issues must be clarified to make SC transplantation a feasible clinical option. In this review, we summarize the recent advances in SC transplantation for SCI, and highlight proposed mechanisms and challenges of SC-mediated therapy. The sparse information available on SC clinical application in patients with SCI is also discussed.

31 January 2018 in Cytotechnology
Verified
Journal Article
Closed access
PDF file
YSYouliang Shen
Youliang Shen
JZJingjing Zhang
Jingjing Zhang
TYTengbo Yu
Tengbo Yu
CQChao Qi
Chao Qi

2 September 2022 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
JZJing Zhang
Jing Zhang
WSWeipeng Shi
Weipeng Shi
DQDi Qu
Di Qu
TYTengbo Yu
Tengbo Yu
CQChao Qi
Chao Qi
HFHaitao Fu
Haitao Fu
Traumatic central nervous system (CNS) disorders have catastrophic effects on patients, and, currently, there is no effective clinical treatment. Cell transplantation is a common treatment for traumatic CNS injury in animals. In recent years, an increasing number of studies have reported that the beneficial effect of transplanted cells for CNS repair is mediated primarily through the extracellular vesicles (EVs) secreted by the cells, in which microRNAs play a major role. Accordingly, numerous studies have evaluated the roles and applications of EVs secreted by different cell types in neurological diseases. Furthermore, due to their unique biological features, EVs are used as disease biomarkers and drug delivery systems for disease prevention and treatment. We discuss current knowledge related to EVs, focusing on the mechanism underlying their effects on traumatic CNS diseases, and summarize existing research on the potential clinical utility of EVs as disease biomarkers and drug delivery systems.

14 June 2023 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
DQDi Qu
Di Qu
DHDie Hu
Die Hu
JZJing Zhang
Jing Zhang
GYGuodong Yang
Guodong Yang
JGJia Guo
Jia Guo
HFHaitao Fu
Haitao Fu

17 January 2025 in Journal of Orthopaedic Surgery and Research
Verified
Journal Article
Open access
PDF file
XTXinyu Tang
Xinyu Tang
XHXinkun Han
Xinkun Han
HFHaitao Fu
Haitao Fu
YSYouliang Shen
Youliang Shen
DZDongfang Zhang
Dongfang Zhang
CQChao Qi
Chao Qi
Surgical management methods for Hepple IV-V osteochondral lesions of the talus (OLT) are diverse. This study aimed to compare the clinical efficacy of arthroscopic autologous cancellous bone grafting and medial malleolar osteotomy combined with autologous periosteal iliac bone grafting in the treatment of medial Hepple IV-V OLT. A retrospective analysis of clinical data from patients who underwent surgical treatment for Hepple IV-V OLT (2020–2023) was conducted. A total of 37 patients were included, with 17 receiving arthroscopic autologous cancellous bone grafting (Group A) and 20 receiving medial malleolar osteotomy combined with autologous periosteal iliac bone grafting (Group B). Compared the surgical time of the two groups; the visual analog scale (VAS) scores, American Orthopaedic Foot & Ankle Society (AOFAS) scores, and ankle joint mobility were used preoperatively, and at 3 months and 1 year postoperatively to assess clinical efficacy; the magnetic resonance observation of cartilage repair tissue (MOCART) 2.0 ankle scores were evaluated at early postoperatively and 1 year postoperatively to assess cartilage repair. The surgical time for Group A was significantly shorter than Group B (P < 0.05). At 3 months and 1 year postoperatively, both groups showed a significant improvements in VAS scores, AOFAS scores, and ankle joint mobility compared to preoperative levels (P < 0.05). At 3 months postoperatively, Group A had significantly higher AOFAS scores and ankle joint mobility than Group B (P < 0.05), while there was no statistically significant difference in VAS scores between the two groups (P > 0.05). At 1 year postoperatively, no significant differences in any of the assessed parameters were found between the two groups (P > 0.05). The MOCART 2.0 ankle scores at 1 year postoperatively were significantly higher than early postoperatively for both groups (P < 0.05), with no significant differences between the two groups (P > 0.05). Arthroscopic autologous cancellous bone grafting showed superior early functional recovery at the 3-month follow-up compared to medial malleolar osteotomy combined with autologous periosteal iliac bone grafting, with shorter surgical time and avoiding osteotomy. Both surgical methods were able to relieve patients’ pain, restore function, and improve cartilage repair. III, retrospective comparative study.